Rekah Pharmaceutical Industry Ltd
TASE:REKA
Rekah Pharmaceutical Industry Ltd
Cash from Investing Activities
Rekah Pharmaceutical Industry Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Cash from Investing Activities
-₪21.5m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-17%
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Cash from Investing Activities
$931m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Cash from Investing Activities
$84.3m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
I
|
InterCure Ltd
TASE:INCR
|
Cash from Investing Activities
₪4.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
20%
|
Mediwound Ltd
NASDAQ:MDWD
|
Cash from Investing Activities
-$34.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-28%
|
|
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
Cash from Investing Activities
-₪1.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Rekah Pharmaceutical Industry Ltd's Cash from Investing Activities?
Cash from Investing Activities
-21.5m
ILS
Based on the financial report for Dec 31, 2023, Rekah Pharmaceutical Industry Ltd's Cash from Investing Activities amounts to -21.5m ILS.
What is Rekah Pharmaceutical Industry Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-17%
Over the last year, the Cash from Investing Activities growth was -60%. The average annual Cash from Investing Activities growth rates for Rekah Pharmaceutical Industry Ltd have been -5% over the past three years , -8% over the past five years , and -17% over the past ten years .